CSIMarket
 



Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
 



 

What are Atara Biotherapeutics Inc's Business Segments?



Atara Biotherapeutics Inc is a leading biotechnology company that specializes in developing innovative therapies for patients with serious diseases. The company focuses on harnessing the power of the immune system to treat cancers, autoimmune diseases, and viral infections. Atara Biotherapeutics offers a diverse range of segments, products, and services to cater to various medical needs.

Segments:
1. Oncology: Atara Biotherapeutics develops cutting-edge therapies to address various types of cancer, including hematologic malignancies such as lymphomas and leukemias, as well as solid tumors like breast, lung, and colorectal cancers.
2. Autoimmune Diseases: The company focuses on creating therapies to combat autoimmune disorders, such as multiple sclerosis (MS), systematic lupus erythematosus (SLE), rheumatoid arthritis (RA), and others. These treatments aim to modulate the immune response to prevent damage to healthy tissues.
3. Viral Infections: Atara Biotherapeutics also works on developing innovative solutions to combat viral infections, including diseases caused by the Epstein-Barr virus (EBV). These therapies aim to target and eliminate viral-infected cells to enhance patients' immune response against the virus.

Products:
1. Allogeneic T-Cell Immunotherapies: Atara Biotherapeutics has developed a series of allogeneic T-cell immunotherapies, including tab-cel' (tabelecleucel) and ATA188. These products involve engineered T-cells derived from donors and can be used to target specific cancers or autoimmune disorders.
2. Mesothelin-Targeted CAR T Cell Therapy: ATARA T-cell therapy effectively targets cancer cells expressing mesothelin antigen and provides a promising therapy option for patients with solid tumors.
3. EBV-Specific T-Cell Immunotherapy: Atara Biotherapeutics has developed therapies such as ATA129 and ATA2271, which are aimed at treating patients with EBV-associated diseases, including post-transplant lymphoproliferative disease (PTLD), nasopharyngeal carcinoma (NPC), and Hodgkin lymphoma.

Services:
1. Clinical Trials: Atara Biotherapeutics offers opportunities for patients to participate in clinical trials for their investigational therapies. These trials allow patients access to potentially life-saving treatments and contribute to scientific advancements.
2. Patient Support Programs: The company provides various patient support programs to ensure the well-being and success of patients undergoing Atara Biotherapeutics' therapies. These programs may include financial assistance, counseling, educational resources, and access to nurse helplines.
3. Research Collaborations: Atara Biotherapeutics collaborates with academic institutions, research organizations, and other biotechnology companies to further advance their scientific knowledge, expand their product pipeline, and develop new therapeutic options for patients.

Overall, Atara Biotherapeutics Inc offers an extensive portfolio of segments, products, and services that address the critical needs of patients with cancer, autoimmune diseases, and viral infections. Their dedication to advancing immunotherapies and improving patients' lives positions them as a leader in the biotechnology industry.
   

Atara Biotherapeutics Inc Tax Rate Companies within the Biotechnology & Pharmaceuticals Industry


Business Segments Q3
Revenues
(in millions $)
Q3
Income
(in millions $)
(Sep 30 2023)
%
(Profit Margin)
Total 5.49 -69.80 -

Growth rates by Segment Q3
Y/Y Revenue
%
(Sep 30 2023)
Q/Q Revenue
%
Q3
Y/Y Income
%
(Sep 30 2023)
Q/Q Income
%
Total 23.21 % 52.23 % - -

To get more information on Atara Biotherapeutics Inc's Total segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com